Search research articles
Contact Us
Filters
Showing results (11-20 of 183) with videos related to
Page
of 19
Sort By:
Journal of Managed Care & Specialty Pharmacy
|
February 25, 2023
Drugs likely subject to Medicare negotiation, 2026-2028
Sean Dickson, Inmaculada Hernandez
JAMA Internal Medicine
|
June 6, 2018
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine
Chester B Good, Inmaculada Hernandez
JAMA
|
October 18, 2022
Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act
Walid F Gellad, Inmaculada Hernandez
JAMA Health Forum
|
October 11, 2022
Decomposition of Expenditures for Insulins Across the Distribution Chain-Insights Into Rising Prices?
Chester B Good, Inmaculada Hernandez
Obesity (Silver Spring, Md.)
|
January 16, 2024
Net prices of new antiobesity medications
Inmaculada Hernandez, Sean D Sullivan
Journal of Managed Care & Specialty Pharmacy
|
February 4, 2020
Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer
Inmaculada Hernandez, Walid F Gellad
JAMA
|
July 29, 2020
Drug Prices, Rebates, and Discounts-Reply
Inmaculada Hernandez, Walid F Gellad
Journal of Managed Care & Specialty Pharmacy
|
July 31, 2023
Estimated discounts generated by Medicare drug negotiation in 2026
Inmaculada Hernandez, Nico Gabriel, Sean Dickson
Pharmacoepidemiology and Drug Safety
|
March 20, 2026
Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium-Glucose Cotransporter 2 Inhibitors
Hongjie Qian, Inmaculada Hernandez, Lanting Yang
Health Affairs (Project Hope)
|
August 7, 2023
Changes In Net Prices And Spending For Pharmaceuticals After The Introduction Of New Therapeutic Competition, 2011-19
Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Page
of 19
Search research articles
Search
Showing results (11-20 of 183) with videos related to
Sort By:
Page
of 19
Journal of Managed Care & Specialty Pharmacy
|
February 25, 2023
Drugs likely subject to Medicare negotiation, 2026-2028
Sean Dickson, Inmaculada Hernandez
JAMA Internal Medicine
|
June 6, 2018
Cost-effectiveness of the Adjuvanted Herpes Zoster Subunit Vaccine
Chester B Good, Inmaculada Hernandez
JAMA
|
October 18, 2022
Pharmaceutical Spending in Fee-for-Service Medicare: Looking Ahead to the Inflation Reduction Act
Walid F Gellad, Inmaculada Hernandez
JAMA Health Forum
|
October 11, 2022
Decomposition of Expenditures for Insulins Across the Distribution Chain-Insights Into Rising Prices?
Chester B Good, Inmaculada Hernandez
Obesity (Silver Spring, Md.)
|
January 16, 2024
Net prices of new antiobesity medications
Inmaculada Hernandez, Sean D Sullivan
Journal of Managed Care & Specialty Pharmacy
|
February 4, 2020
Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer
Inmaculada Hernandez, Walid F Gellad
JAMA
|
July 29, 2020
Drug Prices, Rebates, and Discounts-Reply
Inmaculada Hernandez, Walid F Gellad
Journal of Managed Care & Specialty Pharmacy
|
July 31, 2023
Estimated discounts generated by Medicare drug negotiation in 2026
Inmaculada Hernandez, Nico Gabriel, Sean Dickson
Pharmacoepidemiology and Drug Safety
|
March 20, 2026
Predictors of Discontinuation of Angiotensin Converting Enzyme Inhibitors Use Among Medicare Beneficiaries Using Sodium-Glucose Cotransporter 2 Inhibitors
Hongjie Qian, Inmaculada Hernandez, Lanting Yang
Health Affairs (Project Hope)
|
August 7, 2023
Changes In Net Prices And Spending For Pharmaceuticals After The Introduction Of New Therapeutic Competition, 2011-19
Sean Dickson, Nico Gabriel, Inmaculada Hernandez
Page
of 19